Plasminogen Activator Inhibitor 2 (SERPINB2) (Middle Region) Peptide
Quick Overview for Plasminogen Activator Inhibitor 2 (SERPINB2) (Middle Region) Peptide (ABIN983572)
Target
Origin
Source
Application
-
-
Protein Region
- Middle Region
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-SERPINB2 antibody (Catalog #: ARP56375_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- SERPINB2 (Plasminogen Activator Inhibitor 2 (SERPINB2))
-
Target Type
- Amino Acid
-
Background
-
SERPINB2 inhibits urokinase-type plasminogen activator. The monocyte derived PAI-2 is distinct from the endothelial cell-derived PAI-1.
Alias Symbols: HsT1201, PAI, PAI-2, PAI2, PLANH2
Protein Interaction Partner: RB1,IRF3,PLAU,PRPF8,PSMB1,RB1,SERPINB2,PLAU,RB1
Protein Size: 415 -
Molecular Weight
- 44 kDa
-
Gene ID
- 5055
-
NCBI Accession
- NM_002575, NP_002566
-
UniProt
- P05120
Target
-